Every Drug Can Be Made and Every Disease Can Be Treated
By Building an Open-access Platform with the Most Comprehensive Capabilities and Technologies in the Global Healthcare Industry
Integrity & Dedication, Working Together & Sharing Success; Doing the Right Thing, Doing It Right.
An Open Letter to our Customers from WuXi AppTec Leadership
For more than 20 years, WuXi AppTec has enabled thousands of customers across the pharmaceutical and life sciences industries to discover, develop, and manufacture new medicines to benefit patients.
We have always been guided by our core value of “doing the right thing and doing it right.” And we remain committed to this ethos despite recent unfounded and misleading claims about our company.
Like many of you, we are concerned by a misguided U.S. legislative initiative to target our company without a fair and transparent review of the facts. We are equally concerned by the serious impact the unwarranted allegations and harmful actions would have on patients who rely on the life-saving and innovative work our customers perform in the United States and around the world.
We want to be clear and set the record straight: WuXi AppTec does not pose a national security risk to any country.
While the U.S. government has determined that certain companies do pose such a risk to the United States and has imposed sanctions against them, WuXi AppTec has never been subject to any such determination or sanction. We welcome regulatory oversight of our industry, including the proposed evaluation of biotech companies in the recent legislation. But we strongly object to blanket allegations and preemptive actions against our company without due process.
WuXi AppTec has a strong track record of upholding the highest intellectual property, data and privacy protection standards, as well as maintaining the trust of our customers. Our number one priority continues to be providing customers with resources and capabilities to advance discoveries in the life sciences and deliver treatments to those in need.
As deliberations on this legislation continue, we are actively correcting the unfounded and misleading claims about our company. We are confident that upon considering the facts, U.S. lawmakers will understand that WuXi AppTec does not in any way pose a national security risk to any country. Instead, we serve as a valued contributor to the pharmaceutical and life sciences industries.
Ge Li, Ph.D., Chairman & CEO
Minzhang Chen, Ph.D., Co-CEO
Steve Yang, Ph.D., Co-CEO
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2023 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."
Every drug can be made and every disease can be treated through building an open-access platform with the most comprehensive capabilities and technologies in the global healthcare industry.
—— Ge Li, Ph.D.
Chairman and CEO of WuXi AppTec
WuXi AppTec developed from a laboratory of 7000 square feet to 32 sites worldwide. From 4 co-founders to more than 41,000 employees globally, WuXi AppTec today provides a broad portfolio of R&D and manufacturing services that support over 6,000 collaborative customers around the world.
Our vision is to become the most comprehensive capability and technology platform in the global pharmaceutical and healthcare industry to fulfill the dream that "every drug can be made and every disease can be treated".
Our mission is to continue strengthening our open-access capability and technology platform to enable anyone and any company to discover and develop pharmaceuticals and healthcare products to benefit patients.
Integrity & Dedication, Working Together & Sharing Success; Do the Right Thing and Do It Right.
Put Customers First; Demonstrate Integrity; Strive for Excellence; Execute for Results; Pursue Collaboration and Teamwork; Embrace Change and Innovation.
Environmental, Social and Governance (ESG)
As we forge ahead and see our business continue to grow, we also strive to serve as responsible corporate citizens globally.
Business Conduct and Ethics
As we conduct our business, we have sought to gain the full trust of our customers and to grow alongside them in support of their mission; to adhere to the highest standards of business ethics in all locations in which we operate; and to build a strong security infrastructure and robust corporate culture that protects and preserves the intellectual property and data of our customers. We are implementing green manufacturing and sustainable operations across our business units, helping to improve the environment and the communities in which we operate. We are committed to and maintain an inclusive and vibrant workplace that fosters collaboration among and professional development for all WuXi AppTec employees.
Over 6,000 Customers & Partners Globally
Awards & Recognition
WuXi AppTec constantly promotes the development of global healthcare industry via its open-access capability and technology platform. Adherence to best practices in service delivery has allowed WuXi AppTec to demonstrate outstanding achievement in leadership, technological innovation as well as customer service, and receive recognition from organizations worldwide over the years.
Provide WuXi AppTec at a glance, media package and company photos for media to download